Skip to main content
. 2019 Nov 12;30(12):2823–2833. doi: 10.1111/jce.14260

Figure 5.

Figure 5

Comparison of pre‐ACT values between dabigatran and the three other DOACs combined. ACT, activated clotting time; DOAC, direct oral anticoagulants; P, probability